To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5234 | Tripartin |
Specific inhibitor of the histone H3 lysine 9 demethylase KDM4 in HeLa cells.
More description
|
|
| DCC5233 | Trimipramine |
Antipsychotic and sedative agent as a potent antagonist of H1, 5-HT2A, and alpha1-adrenergic receptors
More description
|
|
| DCC5232 | Trigonellinamide |
Metabolite of nicotinamide; Specific and potent inhibitor of NNMT, increasing histone methylation at H3K4 and methylated H3K4 occupancy at gene promoters
More description
|
|
| DCC5231 | Trifluoroacetyl Lysine |
Novel Bromodomain Binding Mimic of Lysine Acetylation
More description
|
|
| DCC5230 | Trifluoperazine N-glucuronide |
Metabolite of Trifluoperazine; Antidepressant and antipsychotic
More description
|
|
| DCC5229 | Tridecyl 2-aminoacetate Hydrochloride |
Potent NAE-hydrolyzing acid amidase (NAAA) inhibitor
More description
|
|
| DCC5228 | Triciribine Phosphate |
AKT Inhibitor, Enhancing Gemcitabine Activity in Pancreatic Cancer Cells
More description
|
|
| DCC5227 | Triazophos |
EC 3.1.1.7 (Acetylcholinesterase) inhibitor, acting as an insecticide, an acaricide, an agrochemical, and a nematicide
More description
|
|
| DCC5226 | Trenbolone Enanthate |
Potent and long-acting derivative of the hormone Trenbolone
More description
|
|
| DCC5225 | Trehalose-6-phosphate |
Central sugar signal in plants, regulating sucrose use and allocation, underpinning crop growth and development
More description
|
|
| DCC5224 | Trc210258 |
Novel TGR5 agonist, reducing glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
More description
|
|
| DCC5223 | trapoxin B |
Inhibitor of histone deacetylases
More description
|
|
| DCC5222 | Trantinterol |
Novel Highly Selective β2-Adrenoceptor Agonist as an Oral Antiasthmatic Agent
More description
|
|
| DCC5221 | trans-resveratrol-4'-o-glucuronide |
Metabolite of Resveratrol
More description
|
|
| DCC5220 | trans-resveratrol-3-o-glucuronide |
Metabolite of Resveratrol
More description
|
|
| DCC5219 | Trans-ocma |
Natural specific inhibitor of γ-secretase, decreasing amyloid-beta levels without influencing cleavage of Notch, showing strong growth inhibitory effects on cancer cell lines and significant anti-complement activity, also acting as a PTP1B inhibitor
More description
|
|
| DCC5218 | Trans-miyabenol C |
Natural resveratrol trimer, acting as a protein kinase C inhibitor
More description
|
|
| DCC5217 | Trans-cbtbp |
Novel KGA allosteric inhibitor
More description
|
|
| DCC5216 | Trans-bopc1 |
Novel HuR binder, modulating HuR-RNA interactions
More description
|
|
| DCC5215 | Trans-abcd |
Potent and selective NMDA agonist
More description
|
|
| DCC5214 | Trans- Resveratrol-4’-sulfate Sodium Salt |
Metabolite of Resveratrol
More description
|
|
| DCC5213 | Tracizoline |
Potent I 2 -imidazoline receptor agonist
More description
|
|
| DCC5212 | Tp-s1-68 |
Novel Type-I Inhibitor of TIE-2
More description
|
|
| DCC5211 | Tpp-cl2 |
Mitochondria-activatable luciferin (MAL-Probe)
More description
|
|
| DCC5210 | Tpmp-i-2 |
Enhancer of the cytotoxic effect of immunotoxins (ITs) which results in increased apoptosis in different cancer cells
More description
|
|
| DCC5209 | Tpl2-in-i |
Novel tumour progression locus 2 (Tpl2) kinase inhibitor
More description
|
|
| DCC5208 | Tpi-287 |
Novel taxane family member, reducing the brain metastatic colonization of breast cancer cells
More description
|
|
| DCC5207 | Tpi-2659-17 |
Novel Specific Inhibitor of Type I Collagen Production in Fibrosis
More description
|
|
| DCC5206 | Tpi-1917-49 |
Promising amyloid reducing agent by lowering the levels of Aβ.
More description
|
|
| DCC5205 | Tpi1609-10 |
Inhibitor of tyrosine recombinases and Holliday junction-resolving enzymes; Antibacterial
More description
|
|